[Tay-Sachs disease: a case report. Interest of ultrastructural studies of cultured skin fibroblasts (author's transl)]. 1980

F Charbonne, and P Rousseau, and G Malpuech, and A Geneix

Ultrastructural studies of cultured skin fibroblasts derived from an individual affected with Tay-Sachs disease (GM2 gangliosidosis variant B) diagnosed by clinical observation and hexosaminidase A deficiency, revealed several lamellar lysosomal inclusions. These inclusions are not seen in cultured fibroblasts and cultured amniotic fluid cells derived from individuals heterozygotic for Tay-Sachs disease. Normal cells were cultured and observed for comparison.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013661 Tay-Sachs Disease An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry. G(M2) Gangliosidosis, Type I,Gangliosidosis G(M2), Type I,Gangliosidosis GM2, B Variant,Hexosaminidase A Deficiency Disease,Tay-Sachs Disease, B Variant,Amaurotic Familial Idiocy,B Variant GM2 Gangliosidosis,B Variant GM2-Gangliosidosis,Deficiency Disease Hexosaminidase A,Familial Amaurotic Idiocy,GM2 Gangliosidosis, B Variant,GM2 Gangliosidosis, Type 1,GM2 Gangliosidosis, Type I,GM2-Gangliosidosis, Type I,Gangliosidosis GM2 , Type 1,Gangliosidosis GM2, Type I,HexA Deficiency,Hexosaminidase A Deficiency,Hexosaminidase alpha-Subunit Deficiency (Variant B),Sphingolipidosis, Tay-Sachs,Amaurotic Idiocy, Familial,B Variant GM2-Gangliosidoses,Deficiency, Hexosaminidase A,Deficiency, Hexosaminidase alpha-Subunit (Variant B),GM2-Gangliosidosis, B Variant,Hexosaminidase alpha Subunit Deficiency (Variant B),Sphingolipidosis, Tay Sachs,Tay Sachs Disease,Tay Sachs Disease, B Variant,Tay-Sachs Sphingolipidosis,Type I GM2-Gangliosidosis

Related Publications

F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
April 1978, Pediatric research,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
January 1991, Padiatrie und Padologie,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
January 1995, The Turkish journal of pediatrics,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
November 1965, Indian journal of pediatrics,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
June 1980, Archives of pathology & laboratory medicine,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
June 1979, Lijecnicki vjesnik,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
January 1974, Laboratory investigation; a journal of technical methods and pathology,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
January 2022, Rehabilitacion,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
October 2005, Indian journal of pathology & microbiology,
F Charbonne, and P Rousseau, and G Malpuech, and A Geneix
February 1950, Accademia medica,
Copied contents to your clipboard!